Grace Therapeutics logo
Grace Therapeutics
GRCE | NASDAQ
Chart Builder DCF Calculator
$1.75
-$0.06 (-3.31%)
At close: Nov 16, 2026, 4:00 PM ET
$1.75
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Grace Therapeutics Company Profile

Company profile explained

Company Profile

Grace Therapeutics, Inc. specializes in the creation and commercialization of pharmaceutical products, primarily targeting uncommon and neglected diseases, with operations centered in Canada. The company's most advanced experimental treatment is GTX-104, an intravenous infusion designed to address subarachnoid hemorrhage. Its development pipeline further includes GTX-102, an oral mucosal betamethasone spray intended for the management of ataxia-telangiectasia, and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. Established in 2002, the enterprise previously operated under the name Acasti Pharma Inc., before officially adopting Grace Therapeutics, Inc. in October 2024. The company's main offices are located in Princeton, New Jersey.

Key Executives

Name Position
Prashant Kohli Chief Executive Officer & Director
Amresh Kumar Vice President of Program Management
Carrie D'Andrea Consultant
R. Loch MacDonald Member of Scientific Advisory Board & Chief Medical Officer
Robert J. DelAversano Vice President of Finance and Principal Financial & Accounting Officer

Latest SEC Filings

Date Type Title
Oct 26, 2026 4 Filing
Oct 21, 2026 4 Filing
Oct 16, 2026 4 Filing
Oct 13, 2026 4 Filing
Oct 05, 2026 4 Filing
Oct 01, 2026 4 Filing
Oct 01, 2026 4/A [Amend] Filing
Sep 23, 2026 4 Filing
Sep 21, 2026 4 Filing
Sep 21, 2026 4 Filing
View All SEC Filings ➞
Grace Therapeutics
Grace Therapeutics logo
Country United States
IPO Date Feb 7, 2012
Industry Biotechnology
Sector Healthcare
Employees 5
CEO Prashant Kohli

Contact Details

103 Carnegie Center Princeton, New Jersey 08540 United States

Stock Details

Ticker Symbol GRCE
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001444192
CUSIP Number 00439U104
ISIN Number US00439U1043
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.